Indication
Vitiligo
Vitiligo is a chronic, acquired autoimmune disorder of the integumentary system characterized by the selective, progressive destruction of melanocytes. Read more about Vitiligo
0 drugs 0 manufacturers
Drugs that treat it
Common Vitiligo therapies.
No drugs are available
This indication does not currently contain public drugs.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonVitiligo is a chronic, acquired autoimmune disorder of the integumentary system characterized by the selective, progressive destruction of melanocytes.
It can develop at any age across all skin phototypes and populations, though onset frequently occurs before the age of thirty.
Pathophysiologically driven by an aberrant autoreactive immune attack against pigment-producing cells, the condition clinically manifests as well-demarcated, amelanotic white macules and patches on the skin, mucosal membranes, and hair follicles.
Lesions often demonstrate a predilection for the face, acral extremities, and intertriginous areas, presenting as localized, segmental, or widespread nonsegmental patterns.
- nih.gov
Vitiligo is a chronic, acquired autoimmune disorder of the integumentary system characterized by the selective, progressive destruction of melanocytes It can develop at any age across all skin phototypes and populations, though onset frequently occurs before the age of thirty Pathophysiologically driven by an aberrant autoreactive immune attack against pigment-producing cells, the condition clinically manifests as well-demarcated, amelanotic white macules and patches on the skin, mucosal membran...
- nih.gov
Vitiligo is a chronic, acquired autoimmune disorder of the integumentary system characterized by the selective, progressive destruction of melanocytes Lesions often demonstrate a predilection for the face, acral extremities, and intertriginous areas, presenting as localized, segmental, or widespread nonsegmental patterns
- medlineplus.gov
It can develop at any age across all skin phototypes and populations, though onset frequently occurs before the age of thirty
- medlineplus.gov
Pathophysiologically driven by an aberrant autoreactive immune attack against pigment-producing cells, the condition clinically manifests as well-demarcated, amelanotic white macules and patches on the skin, mucosal membranes, and hair follicles
- medlineplus.gov
Lesions often demonstrate a predilection for the face, acral extremities, and intertriginous areas, presenting as localized, segmental, or widespread nonsegmental patterns
Personalize your experience
Follow Vitiligo and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.